報價延遲最少15分鐘:2025/02/01 14:38 EST
|
|
|
|
|
||||||||||||
|
|
|
|
|
23.81 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.36/--
|
|
企業價值
969.22M
|
| 資產負債 |
|
每股賬面淨值
不適用
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
12.00M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/02/01 14:38 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product include the iLet Bionic Pancreas (iLet). The Company operates as single segment, focused on the development, manufacture and sale of the iLet. |